Date: 27-Apr-2020

Natco Pharma Kothurs Formulation Facility Gets EIR From US FDA

Natco Pharma Limited has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for Kothur's formulation facility.

"The inspection is conducted at its drug formulations facility in Kothur village, Telangana, India, during the period from March 2 to 6, 2020," says Natco Pharma.

Natco Pharma is an Indian pharmaceutical company based in Hyderabad, which makes finished dosage formulations and active pharmaceutical ingredients. It is the market leader in branded oncology medicines in India, and among the country's top three in producing hepatitis C drugs.